Egetis Therapeutics: Explores RTH-beta as the next indication for tiratricol/Emcitate - Redeye
Bildkälla: Stockfoto

Egetis Therapeutics: Explores RTH-beta as the next indication for tiratricol/Emcitate - Redeye

Redeye comments on the news that Egetis has decided to explore RTH-beta as the next indiction for tiratricol/Emcitate.

Redeye comments on the news that Egetis has decided to explore RTH-beta as the next indiction for tiratricol/Emcitate.
Börsvärldens nyhetsbrev
ANNONSER